Evidence map›Paper›PMID 42513421›Full record

ArticleJournal of clinical medicine2026

Upadacitinib Reduces Rates of Hospitalization in Ulcerative Colitis: A Large-Scale Nationwide Cohort Study.

Chiaki Maeyashiki, Nobuharu Tamaki, Yuki Tanaka, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Masayuki Kurosaki

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chiaki MaeyashikiDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan.ORCID 0000-0003-3026-7438
Nobuharu TamakiDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan.
Yuki TanakaDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan.
Yutaka YasuiDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan.ORCID 0000-0002-6117-4990
Kaoru TsuchiyaDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan.
Hiroyuki NakanishiDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan.
Masayuki KurosakiDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan.ORCID 0000-0001-7016-8931

Funding

Japan Agency for Medical Research and Development JP26fk0210174Japan Agency for Medical Research and Development JP26fk0210186Japan Agency for Medical Research and Development JP26fk0210188Japan Agency for Medical Research and Development JP26fk0310535Japan Agency for Medical Research and Development JP26fk0310545Japan Agency for Medical Research and Development JP26fk0310551
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hospitalizationulcerative colitisupadacitinib

Identifiers

PMID42513421
PMCPMC13412781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.